FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 3211301 · Received July 8, 2013

Report

Report Number
2124215-2013-08772
Event Type
Injury
Date Received
July 8, 2013
Date of Event
May 8, 2013
Report Date
June 17, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
LA
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

ANALYSIS IS ON-GOING. THIS REPORT WILL BE UPDATED UPON COMPLETION OF ANALYSIS.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THIS ICD HAD NO TELEMETRY. THE DEVICE WAS THOROUGHLY INSPECTED AND ANALYZED. EXTERNAL VISUAL INSPECTION OF THE DEVICE REVEALED NO ANOMALIES. THE DEVICE CASE WAS OPENED TO FACILITATE ANALYSIS OF THE INTERNAL COMPONENTS. THE BATTERY WAS SEPARATED FROM THE OTHER DEVICE ELECTRONICS AND THE OVERALL CURRENT DRAW OF THE CIRCUITRY WAS MEASURED. A NORMAL CURRENT DRAIN WAS OBSERVED WITHIN THE CIRCUITRY. THIS BEHAVIOR IS CONSISTENT WITH DEVICES WHERE A LATENT CURRENT LEAKAGE PATH HAS OCCURRED WITHIN THE BATTERY ITSELF, RESULTING IN A PARTIAL DEPLETION OF THE BATTERY.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) COULD NOT BE INTERROGATED. IT WAS NOTED THAT PREVIOUS REMOTE INTERROGATIONS HAD A WARNING MESSAGE INDICATING THAT ¿VOLTAGE WAS TOO LOW FOR REMAINING CAPACITY.¿ THE DEVICE WAS EXPLANTED DUE TO PREMATURE BATTERY DEPLETION AND REPLACED WITHOUT INCIDENT. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

--

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
311502 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 80 YR Hospitalization| L| R E110| 0175| 4469